Avandia & Congestive Heart Failure

Schmidt & Clark, LLP is No Longer Taking These Cases - If you feel that you may have a potential case, we urge you to contact another law firm adequately suited to handle your case.

Avandia Congestive Heart Failure: Quick Facts

Quick Facts About Avandia & Congestive Heart Failure

  • Congestive heart failure occurs when the heart can no longer pump enough blood to maintain adequate circulation. Because the heart doesn’t pump properly, fluids often build up in the lungs.
  • More than 65% of deaths among diabetic patients are heart disease related.
  • Avandia has been shown in studies to increase the risk of heart attack by 43% and risk cardiovascular death by 64%.
  • Avandia was approved for treatment of type 2 diabetes in 1999, a serious and life threatening disease that affects 18 to 20 million Americans.
  • The medical term for heart attack is myocardial infarction. A heart attack is also sometimes referred to as a coronary thrombosis or coronary occlusion.
  • On June 7, 2007 the FDA issued a black box warning for Avandia. The “black box” warning is the strongest warning that the FDA adds to labels on medications that may pose a health risk to others.
Awards & recognition